Chamath Palihapitiya, the outspoken 'King of SPACs,' turns his eyes to biotech with plans to cash an $800M blank check
Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.
He’s been called the “SPAC King” and the “Pied Piper of SPACs.” He’s a co-owner of the NBA’s Golden State Warriors. He has over 1.5 million followers on Twitter, and was an early executive at Facebook.
Now, Chamath Palihapitiya is turning his attention to biotech with a laser focus on the industry standing out from a typical SPAC syndicate.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 129,500+ biopharma pros reading Endpoints daily — and it's free.